Conserved responses to trichostatin A in rodent lungs exposed to endotoxin or stretch

Area of Science:

• Pulmonary pharmacology
• Molecular biology
• Inflammation research

Background:

• Histone deacetylase (HDAC) inhibitors are investigated as drug targets for pulmonary cancer and inflammatory lung diseases like asthma and COPD.
• The role of HDAC inhibition in inflammation (pro- vs. anti-inflammatory) remains debated.
• Understanding HDACs' impact on lung inflammation is crucial for therapeutic development.

Purpose of the Study:

• To investigate the effects of HDAC inhibition on gene expression and protein release in response to pro-inflammatory stimuli in isolated rodent lungs.
• To determine if HDAC inhibition has pro- or anti-inflammatory effects in the context of endotoxin and mechanical stress.
• To compare the effects of trichostatin A (TSA) with dexamethasone and assess potential additive effects.

Main Methods:

• Analysis of 8 genes upregulated by endotoxin (rat lungs) and mechanical stress (mouse lungs).
• Treatment with HDAC inhibitor trichostatin A (TSA) under various conditions (control, stimulated, with dexamethasone).
• Measurement of gene expression and protein release (TNF, MIP-2alpha, IL-6).

Main Results:

• TSA modulated gene expression consistently across stimuli and species, upregulating some genes (Tnf, Cxcl2) and downregulating others (Cxcl10, Timp1, Selp, Il6).
• At the protein level, TSA reduced stimulated release of TNF, MIP-2alpha, and IL-6, suggesting post-transcriptional effects.
• Anti-inflammatory effects of TSA were additive to dexamethasone, indicating distinct mechanisms of action.

Conclusions:

• Pro-inflammatory stimuli induce distinct gene sets regulated by HDACs in a consistent manner across rodent species.
• HDAC inhibition demonstrates anti-inflammatory effects in isolated lungs, impacting both gene expression and protein release.
• Findings support the potential of HDAC inhibitors as anti-inflammatory agents for lung diseases.